• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The isolation and characterization of novel susceptibility gene for familial ovarian cancer.

Research Project

Project/Area Number 12557135
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Obstetrics and gynecology
Research InstitutionNIIGATA UNIVERSITY

Principal Investigator

TANAKA Kenichi  Graduate School of Medical and Dental Sciences, NIIGATA UNIVERSITY, Professor, 大学院・医歯学総合研究科, 教授 (10126427)

Co-Investigator(Kenkyū-buntansha) FUJITA Kazuyuki  Medical Hospital, NIIGATA UNIVERSITY, Assistant, 医歯部・附属病院, 助手 (80219005)
TAKAKUWA Koichi  Graduate School of Medical and Dental Sciences, NIIGATA UNIVERSITY, Associate Professor, 大学院・医歯学総合研究科, 助教授 (80187939)
相田 浩  新潟大学, 医学部・附属病院, 助手 (50313531)
常木 郁之輔  新潟大学, 医学部・附属病院, 助手 (50303152)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥11,400,000 (Direct Cost: ¥11,400,000)
Fiscal Year 2001: ¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 2000: ¥7,600,000 (Direct Cost: ¥7,600,000)
KeywordsFAMILIAL OVARIAN CANCER / BRCA1 / BRCA2 / POSITIONAL CLONING / 卵巣癌 / 家族発生 / 家族性卵巣がん / 連鎖解析
Research Abstract

We analyzed genetic alterations in BRCA1 and BRCA2 genes among 82 ovarian cancer families in Japan. Using a direct sequencing method, 45 out of the 82 ovarian cancer families were found to carry BRCA1 or BRCA2 germline mutations (40 with BRCA1 and 5 with BRCA2). In 24 independent mutations of BRCA1, five recurrent mutations were found and two of them, the T307A and C2919T mutations, were detected in 7 and 8 independent families, respectively. In addition, 18 mutations of BRCA1 and 4 mutations of BRCA2 have never been described previously. There was a significantly higher proportion of tumors with serous adenocarcinoma and of cases of advanced stages in the BRCA1 or BRCA2 cases than those of the controls. On the other hand, there were no differences of mean age at diagnosis between patients with BRCA1 or BRCA2 mutation and those of the controls. Our results indicate that the T307A and C2919T mutations of BRCA1 appear to be common founder mutations unique to the Japanese population. We performed genome-wide linkage analysis in 58 patients and 9 unaffected members among 28 families with no mutation in BRCA1 or BRCA2 employing a set of 410 microsatellite markers. We initially screened the whole genome including the X-chromosome by a nonparametric method using the GENEHUNTER program. As a result, chromosome 3p22-25 showed a suggestive score for linkage (LOD = 3.49 and NPL = 2.77 at D3S3611) based on a multipoint analysis. It was observed that the frequency of LOH was more than 50% only in tumor tissues from patients with no mutation in BRCA1 or BRCA2 but not in those with BRCA1 mutation at 4 markers in this region.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Masayuki Sekine et al.: "Localization of novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25"Hum. Mol. Genet.. 10. 1421-1429 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masayuki Sekine et al.: "Mutation analysis of BRCA 1 and BRCA2 and clinocopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese populations"Cli. Cancer Res.. 7. 3134-3150 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masayuki Sekine, et al.: "Localization of a novel Susceptibility gene for familial ovarian cancer To chromosome 3p22-p25"Hum.Mol. Genet. 10. 1421-29 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masayuki Sekne, et al.: "Mutation analysis of BRCA1 and BRCA2 and clinocopathologic analysis of Ovarian cancer in 82 ovarian cancer families : two Common founder mutations of BRCA1 in Japanese populations"Cli. Cancer Res.. 7. 3134-50 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masayuki Sekine, Kenichi Tanaka: "Localization of a novel suscaptibility gene for familial ovarian cancer to chromosome 3p22-25"Human Molecular Genetics. 10. 1421-1429 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Masayuki Sekine, Kenichi Tanaka: "Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer 8z ovarian cancel familiar, two common finder mutations of BRCA1 in Japanese population"Clinical Cancer Research. 7. 3144-3150 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hiroshi Nagata, Kenichi Tanaka: "Haplotypes of BRCA1 Mutation be in Japanese Ovarian and Breast-ovarian cancer families : A Novel Method to Find BRCA1 Associated Ovarian Cancer"Acta Medica et Biologica. (in press).

    • Related Report
      2001 Annual Research Report
  • [Publications] Youichi Aoki, Kenichi Tanaka: "Neoajubant Chemotherapy Using-Low-Dose Consecutive Intraartrial Infusions of Cisplatin Combained eith 5-Fluorouracil for leally Advanced carvical denocareiheina"Gynecologic Oncology. 81. 496-499 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hiroshi Matsushita, Kenichi Tanaka: "Disseminated Intravascular Coagulation Associated with Intratumoral Hemorrhage of Ovarian Cancer"Gynecologic and Obstetric Investigation. 51. 274-276 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Mitsuru Matsushita, Kenichi Tanaka: "MR imaging underesrimates stromal inyssion in patients with adenocarcinoma of the uterine cergix"Eur. J. Crynaec. Oncol. 22. 201-203 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kacsunori Kashima,Takeshi Oite,Kenichi Tanaka: "Screening of BRCA1 mutation using Tmmunohistochemical staining with C-terminal and N-terminal antibodies in familial ovarian cancers"Jpn.J.Cancer Res. 91. 399-409 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Takehiro Serikawa,Norio Suzuki,Kenichi Tanaka: "Anew cationic liposome for efficient gene delivery with serum cultured human cells : a quantitative analysis using two independent fluorescent probes"Biochimical et Biophysica Acta. 1467(2). 419-430 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yoichi Aoki,Jkunosuke Tsuneki,Kenichi Tanaka: "Analysis of TH1 and TH2 cells by Intracellular cytokine detection with flow cytometry in patients with ovarian cancer"Gynecologic and Obstetric Investigation. 50(3). 207-211 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi